Meristem Therapeutics S.a.

Edulis

Genevieve Spik

Veronique Gruber

Bertrand Merot

Philippe Bournat

Dominique Legrand

Valerie Salmon

The invention concerns the use of a recombinant nucleotide sequence containing a cDNA coding for a lactoferrin, in particular human lactoferrin, or the derived proteins, and elements enabling a plant cell to produce lactoferrin or the derived proteins, coded by the cDNA, in particular a transcription promoter and terminator identified by the plant cell transcription machinery, to transform plant cells in order to obtain, from these cells, or plants obtained therefrom, lactoferrin or derived proteins.

Recombinant lactoferrins, methods of production from plants and uses thereof

The invention concerns the use of a recombinant nucleotide sequence containing a cDNA coding for a lactoferrin, in particular human lactoferrin, or the derived proteins, and elements enabling a plant cell to produce lactoferrin or the derived proteins, coded by said cDNA, in particular a transcription promoter and terminator identified by the plant cell transcription machinery, to transform plant cells in order to obtain, from these cells, or plants obtained therefrom, lactoferrin or derived proteins.

Recombinant lactoferrin, methods of production from plants and uses

Growing community of inventors

Marcq en Barouel, France

Genevieve Spik